10.6 CHAMPLAIN
Summary
CHAMPLAIN was a prospective, phase 2, multicenter, open-label, 26-week study enrolling 55 patients with treatment-resistant DME and a history of pars plana vitrectomy in the study eye; most of the study eyes (n=42) were pseudophakic at baseline. All eyes received a single injection of 0.7 mg dexamethasone intravitreal implant.
Quiz Module 10.6
Attention: you are not signed in!
To validate your answers and keep track of your progress please sign in or register a new account
To validate your answers and keep track of your progress please sign in or register a new account
1. What was the focus of the CHAMPLAIN study?
2. In vitrectomized eyes, dexamethasone intravitreal implant was shown to improve what?